VEGF: an update on biological and therapeutic aspects

被引：329

作者：

Farrara, N ^{[1
]}

机构：

[1] Genentech Inc, Dept Mol Oncol, S San Francisco, CA 94080 USA

来源：

CURRENT OPINION IN BIOTECHNOLOGY | 2000年 / 11卷 / 06期

关键词：

D O I：

10.1016/S0958-1669(00)00153-1

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen and an angiogenic inducer as well as a mediator of vascular permeability. VEGF is essential for developmental angiogenesis and is also required for female reproductive functions and endochondral bone formation. Substantial evidence also implicates VEGF in tumors and intraocular neovascular syndromes. Currently, several clinical trials are ongoing to test the hypothesis that the inhibition of VEGF activity may be beneficial for these conditions.

引用

页码：617 / 624

页数：8

共 108 条

[51] HENRY TD, 1999, J AM COLL CARDIOL, V33, P874
[52] Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice
Hiratsuka, S
Minowa, O
Kuno, J
Noda, T
Shibuya, M
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) : 9349 - 9354
[53] Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors - Generation of receptor-selective VEGF variants by site-directed mutagenesis
Keyt, BA
Nguyen, HV
Berleau, LT
Duarte, CM
Park, J
Chen, H
Ferrara, N
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (10) : 5638 - 5646
[54] The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency
Keyt, BA
Berleau, LT
Nguyen, HV
Chen, H
Heinsohn, H
Vandlen, R
Ferrara, N
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (13) : 7788 - 7795
[55] INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR-INDUCED ANGIOGENESIS SUPPRESSES TUMOR-GROWTH INVIVO
KIM, KJ
LI, B
WINER, J
ARMANINI, M
GILLETT, N
PHILLIPS, HS
FERRARA, N
[J]. NATURE, 1993, 362 (6423) : 841 - 844
[56] Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity
Klement, G
Baruchel, S
Rak, J
Man, S
Clark, K
Hicklin, DJ
Bohlen, P
Kerbel, RS
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (08) : R15 - R24
[57] The kallikrein-kinin system, but not vascular endothelial growth factor, plays a role in the increased vascular permeability associated with ovarian hyperstimulation syndrome
Kobayashi, H
Okada, Y
Asahina, T
Gotoh, J
Terao, T
[J]. JOURNAL OF MOLECULAR ENDOCRINOLOGY, 1998, 20 (03) : 363 - 374
[58] Signaling angiogenesis and lymphangiogenesis
Korpelainen, EI
Alitalo, K
[J]. CURRENT OPINION IN CELL BIOLOGY, 1998, 10 (02) : 159 - 164
[59] INDUCIBLE GENE TARGETING IN MICE
KUHN, R
SCHWENK, F
AGUET, M
RAJEWSKY, K
[J]. SCIENCE, 1995, 269 (5229) : 1427 - 1429
[60] Kvanta A, 1996, INVEST OPHTH VIS SCI, V37, P1929

← 1 2 3 4 5 6 7 8 9 10 →